Capodici John, Karikó Katalin, Weissman Drew
Department of Medicine, University of Pennsylvania, Philadelphia 19104, USA.
J Immunol. 2002 Nov 1;169(9):5196-201. doi: 10.4049/jimmunol.169.9.5196.
RNA interference (RNAi) is an ancient antiviral response that processes dsRNA and associates it into a nuclease complex that identifies RNA with sequence homology and specifically cleaves it. We demonstrate that RNAi mediated by 21-bp dsRNA specifically inhibits HIV-1 infection of permanent cell lines and primary CD4(+) T cells. Inhibition of HIV replication was measured by p24 Gag protein content in supernatant, Northern blot analysis, and DNA PCR for products of reverse transcription. The inhibition occurred at two points in the viral life cycle, after fusion and before reverse transcription and during transcription of viral RNA from integrated provirus. Treatment of HIV-infected activated CD4(+) T cells with a fluorine-derivatized siRNA that is resistant to RNase A yielded similar inhibition of HIV infection. In addition, the derivatized siRNA could be delivered without lipofectin complexing and in the presence of serum. The identification of RNAi activity against HIV-1 presents a new approach to study viral infections and a proof of concept of RNAi antiviral activity in mammalian cells.
RNA干扰(RNAi)是一种古老的抗病毒反应,它处理双链RNA并将其组装成一种核酸酶复合物,该复合物可识别具有序列同源性的RNA并特异性切割它。我们证明,由21个碱基对的双链RNA介导的RNAi可特异性抑制HIV-1对永生化细胞系和原代CD4(+) T细胞的感染。通过检测上清液中p24 Gag蛋白含量、Northern印迹分析以及针对逆转录产物的DNA PCR来测定HIV复制的抑制情况。这种抑制作用发生在病毒生命周期的两个阶段,一是在融合之后、逆转录之前,二是在从整合前病毒转录病毒RNA的过程中。用对RNase A有抗性的氟衍生化小干扰RNA(siRNA)处理HIV感染的活化CD4(+) T细胞,对HIV感染产生了类似的抑制作用。此外,衍生化的siRNA无需与脂质体复合且在有血清存在的情况下即可递送。针对HIV-1的RNAi活性的鉴定为研究病毒感染提供了一种新方法,并证明了RNAi在哺乳动物细胞中的抗病毒活性概念。